X
X
X

Filters close
28-Sep-2023 11:05 PM EDT
Precision medicine navigators increase genomic testing rates for Black patients with prostate cancer
American Society for Radiation Oncology (ASTRO)

The presence of a clinical navigator to act as a liaison between people with prostate cancer and the health care system greatly increases the likelihood that patients, especially Black patients, will receive advanced testing that can help predict the severity of their disease and guide treatment, a new study suggests.

Released: 1-Oct-2023 1:20 PM EDT
Shorter course of radiation therapy is safe for patients with early-stage breast cancer who have undergone mastectomy and reconstruction
Dana-Farber Cancer Institute

Researchers at Dana-Farber Brigham Cancer Center have found that a shorter course of radiation therapy after mastectomy and breast reconstruction surgery provides the same protection against breast cancer recurrence and equivalent physical side-effects but substantially reduces life disruption and financial burden for patients.

28-Sep-2023 10:05 PM EDT
Short-course radiation as effective as standard treatment for patients who opt for breast reconstruction after mastectomy
American Society for Radiation Oncology (ASTRO)

In a first-of-its-kind study, people with breast cancer who underwent implant-based breast reconstruction immediately following a mastectomy reported that getting fewer, higher doses of radiation was just as effective as standard radiation, did not increase side effects and saved them time and money.

28-Sep-2023 10:05 PM EDT
High-dose radiation offers new treatment option for older patients with inoperable kidney tumors
American Society for Radiation Oncology (ASTRO)

Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted, high-dose radiation, a new study from Australian and Dutch researchers suggests.

28-Sep-2023 11:05 PM EDT
Sexual activity and vaginal dilation associated with fewer side effects after cervical cancer treatment
American Society for Radiation Oncology (ASTRO)

People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical cancer are at lower risk for long-term side effects, according to a new study from researchers in Austria.

28-Sep-2023 11:05 PM EDT
Liquid biopsies can rapidly detect residual disease following cervical chemoradiation, study finds
American Society for Radiation Oncology (ASTRO)

Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood accurately identified patients with a high risk of cervical cancer recurrence after the completion of chemoradiation, a new study confirms.

29-Sep-2023 11:00 AM EDT
MD Anderson Research Highlights: ASTRO 2023 Special Edition
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.

27-Sep-2023 2:05 PM EDT
Embargoed Sylvester Comprehensive Cancer Center ASTRO 2023 Tip Sheet
Sylvester Comprehensive Cancer Center

Many physician-scientists and other researchers from Sylvester Comprehensive Cancer Center will make oral or poster presentations and participate in panel discussions at the American Society of Radiation Oncology (ASTRO) 2023 annual meeting in San Diego, Oct. 1-4.

Newswise: True Progression or Pseudoprogression in Glioblastoma Patients?
27-Sep-2023 1:05 PM EDT
True Progression or Pseudoprogression in Glioblastoma Patients?
Sylvester Comprehensive Cancer Center

EMBARGOED ASTRO PRESENTATION: Is it true progression or pseudoprogression in tumor growth? That’s the critical question for radiation and medical oncologists treating patients with glioblastoma. Sylvester researchers will present results from two recent studies at ASTRO 2023.

26-Sep-2023 5:30 PM EDT
High cure rate, low toxicity maintained with shortened radiation treatment for intermediate risk prostate cancer, study finds
American Society for Radiation Oncology (ASTRO)

People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests.

Newswise: $3.3M grant awarded to UTHealth Houston to study digital patient-reported symptom monitoring tool for patients with head and neck cancer
Released: 29-Sep-2023 4:05 PM EDT
$3.3M grant awarded to UTHealth Houston to study digital patient-reported symptom monitoring tool for patients with head and neck cancer
University of Texas Health Science Center at Houston

A five-year, $3.3 million grant to study symptom management in patients with head and neck cancer has been awarded to researchers from UTHealth Houston by the National Cancer Institute (1R01CA282149), part of the National Institutes of Health.

Released: 29-Sep-2023 2:35 PM EDT
Revised Framework for Reviewing Potential Carcinogens to Reduce Animal Testing
Institute for the Advancement of Food and Nutrition Sciences

More reliance on modeling and test tube-based data to lower reliance on test animals.

Newswise: Research Highlights for September 2023
Released: 29-Sep-2023 2:05 PM EDT
Research Highlights for September 2023
University of Utah Health

Huntsman Cancer Institute shines the spotlight on new discoveries and cutting-edge cancer research. This month, researchers found that increasing access for Black people with prostate cancer may save lives. Also, the first patient in a new small cell lung cancer clinical trial has been enrolled, researchers are using an app to help adolescents and young adults manage cancer symptoms, and investigators are trying to reduce cognitive side-effects after chemotherapy.

Newswise: With Regular Screening, More Women Survive Breast Cancer
Released: 29-Sep-2023 11:00 AM EDT
With Regular Screening, More Women Survive Breast Cancer
American Cancer Society (ACS)

To mark Breast Cancer Awareness Month, the American Cancer Society highlights its guidelines encouraging average-risk women to begin regular screening mammograms at age 45, with the option to begin screening as early as age 40.

access_time Embargo lifts in 2 days
Embargo will expire: 2-Oct-2023 11:00 AM EDT Released to reporters: 29-Sep-2023 11:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 2-Oct-2023 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: A vision for rare cancer research: $5 million commitment launches CURE, a rare cancer initiative, at Case Comprehensive Cancer Center
Released: 29-Sep-2023 10:30 AM EDT
A vision for rare cancer research: $5 million commitment launches CURE, a rare cancer initiative, at Case Comprehensive Cancer Center
Case Western Reserve University

The CURE initiative aims to build on Case CCC’s collaborative nature to create a national network among U.S. cancer centers, and to catalyze innovative bench-to-bedside approaches to identifying and treating rare cancers.

Newswise: Study identifies new pathway to suppressing autoimmunity
25-Sep-2023 2:05 PM EDT
Study identifies new pathway to suppressing autoimmunity
The Rockefeller University Press

Researchers at Stanford University School of Medicine, Yale University School of Medicine, and the Hospital for Special Surgery Research Institute have uncovered new details about how the immune system prevents the production of antibodies that can recognize and damage the body’s own, healthy tissues. The study, to be published September 29 in the Journal of Experimental Medicine (JEM), also reveals how this process is impaired in autoimmune disorders such as systemic sclerosis and systemic lupus erythematosus and suggests potential new strategies to treat these diseases.

Newswise:Video Embedded global-speakers-cutting-edge-topics-surgical-theater-on-tap-for-desai-sethi-urology-institute-s-urology-on-the-beach-2024
VIDEO
Released: 29-Sep-2023 8:05 AM EDT
Global Speakers, Cutting-edge Topics, Surgical Theater on Tap for Desai Sethi Urology Institute’s Urology on the Beach 2024
University of Miami Health System, Miller School of Medicine

Desai Sethi Urology Institute at the University of Miami Miller School of Medicine will host its second annual, in-person Urology on the Beach meeting, January 19 to 21, 2024, at the Fontainebleau Hotel in Miami Beach.

Newswise: Palex and Inbiomotion introduce pioneering test to aid
oncologists in predicting recurrence and survival rates in breast
cancer patients
Released: 29-Sep-2023 8:05 AM EDT
Palex and Inbiomotion introduce pioneering test to aid oncologists in predicting recurrence and survival rates in breast cancer patients
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Spain is the first country in the world to have this technology • Results showing the clinical utility of the test were published in Lancet Oncology and the Journal of National Cancer Institute • The test is now available to oncologists and pathologists and will benefit an estimated 24,000 patients each year in Spain

access_time Embargo lifts in 2 days
Embargo will expire: 2-Oct-2023 2:25 PM EDT Released to reporters: 28-Sep-2023 11:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 2-Oct-2023 2:25 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

120 of 23649

close
3.95627